Insiders · Profile

Sablich Kim

EVP, GM of U.S., Commercial Ma at Jazz Pharmaceuticals. Filing since 11 Nov 2021. CIK 0001758790

Company
Date
Role
Action
Shares
Amount
Of holding
8 Mar 2023
EVP, GM of U.S., Commercial Ma
Sold, plan not stated
3,013
$421.04K
9.0%
7 Jun 2022
EVP & GM, North America
Sold, plan not stated
2,441
$368.71K
9.0%
6 Jun 2022
EVP & GM, North America
Sold, plan not stated
1,388
$211.18K
4.9%
11 Nov 2021
EVP & GM, North America
Sold, plan not stated
2,748
$371.00K
11.5%
4 decisions on file.